Sign In
Pharma
Glenmark to sell nasal spray to treat adult Covid-19 patients
Glenmark Pharma inks licensing agreement to commercialize its innovative nasal spray Ryaltris
Glenmark Pharma gets USFDA nod for nasal spray, Ryaltris
Glenmark launches Type 2 Diabetes fixed-dose combination drug in India
Pharma Giants Glenmark, Aurobindo recall products in US
Glenmark gets USFDA approval for Clindamycin Phosphate Foam 1%
Markets
Glenmark concludes study on Covid drug Favipiravir
Glenmark to market COVID treatment spray SaNOtize in India, other Asian markets
IPO
Glenmark Life Sciences IPO subscription opens 27th July
Study supports favipiravir's safety: Glenmark
Glenmark nasal spray for allergic rhinitis
Glenmark Pharma gets USFDA nod for Chlorpromazine Hydrochloride tablets; share price gains
